BackAdc Therapeutics SA Overview

Adc Therapeutics SA Accounts Payable

Adc Therapeutics SA's accounts payable is $5.3M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$5.29M
66.04% YoYΔ $-10.30M vs prior year quarter

Peer average

Loading

Adc Therapeutics SA Accounts Payable History

Loading

Adc Therapeutics SA vs. peers: Accounts Payable Comparison

Loading

Adc Therapeutics SA Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Adc Therapeutics SA (ADCT) FAQ

As of the most recent data (March 2026), ADCT shows a accounts payable of $5.3M. That compares with $16M in the prior-year period — down 66.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ADCT's accounts payable is now $5.3M (was $16M) — a 66.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Adc Therapeutics SA is outperforming or lagging.

Tracking ADCT's accounts payable over time shows whether Adc Therapeutics SA is scaling, shrinking, or reshaping that part of the business. The current reading is $5.3M That compares with $16M in the prior-year period — down 66.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Adc Therapeutics SA's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $5.3M) with ownership activity and broader fundamentals.

Adc Therapeutics SA's accounts payable is $5.3M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.